Mesial Prefrontal Cortex Degeneration in Amyotrophic Lateral Sclerosis: A High-Field Proton MR Spectroscopy Study

References

1. 1.↵
   1. Ringholz GM,
   2. Appel SH,
   3. Bradshaw M,
   4. et al

   . Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology 2005; 65: 586–90

   Abstract/FREE Full Text
2. 2.↵
   1. Strong MJ,
   2. Grace GM,
   3. Orange JB,
   4. et al

   . A prospective study of cognitive impairment in ALS. Neurology 1999; 53: 1665–70

   Abstract/FREE Full Text
3. 3.↵
   1. Lomen-Hoerth C,
   2. Murphy J,
   3. Langmore S,
   4. et al

   . Are amyotrophic lateral sclerosis patients cognitively normal? Neurology 2003; 60: 1094–97

   Abstract/FREE Full Text
4. 4.↵
   1. Barson FP,
   2. Kinsella GJ,
   3. Ong B,
   4. et al

   . A neuropsychological investigation of dementia in motor neurone disease (MND). J Neurol Sci 2000; 180: 107–13

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Wilson CM,
   2. Grace GM,
   3. Munoz DG,
   4. et al

   . Cognitive impairment in sporadic ALS: a pathologic continuum underlying a multisystem disorder. Neurology 2001; 57: 651–57

   Abstract/FREE Full Text
6. 6.↵
   1. Ferrer I,
   2. Roig C,
   3. Espino A,
   4. et al

   . Dementia of frontal lobe type and motor neuron disease. A Golgi study of the frontal cortex. J Neurol Neurosurg Psychiatry 1991; 54: 932–34

   Abstract/FREE Full Text
7. 7.↵
   1. Geser F,
   2. Martinez-Lage M,
   3. Robinson J,
   4. et al

   . Clinical and pathological continuum of multisystem TDP-43 proteinopathies. Arch Neurol 2009; 66: 180–89

   CrossRefPubMedWeb of Science
8. 8.↵
   1. Yoshida M

   . Amyotrophic lateral sclerosis with dementia: the clinicopathological spectrum. Neuropathology 2004; 24: 87–102

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Neumann M,
   2. Sampathu DM,
   3. Kwong LK,
   4. et al

   . Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006; 314: 130–33

   Abstract/FREE Full Text
10. 10.↵
    1. Chang JL,
    2. Lomen-Hoerth C,
    3. Murphy J,
    4. et al

    . A voxel-based morphometry study of patterns of brain atrophy in ALS and ALS/FTLD. Neurology 2005; 65: 75–80

    Abstract/FREE Full Text
11. 11.↵
    1. Agosta F,
    2. Pagani E,
    3. Rocca MA,
    4. et al

    . Voxel-based morphometry study of brain volumetry and diffusivity in amyotrophic lateral sclerosis patients with mild disability. Hum Brain Mapp 2007; 28: 1430–38

    CrossRefPubMedWeb of Science
12. 12.↵
    1. Abe K,
    2. Fujimura H,
    3. Toyooka K,
    4. et al

    . Cognitive function in amyotrophic lateral sclerosis. J Neurol Sci 1997; 148: 95–100

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Abrahams S,
    2. Goldstein LH,
    3. Kew JJ,
    4. et al

    . Frontal lobe dysfunction in amyotrophic lateral sclerosis. A PET study. Brain 1996; 119: 2105–20

    Abstract/FREE Full Text
14. 14.↵
    1. Lloyd CM,
    2. Richardson MP,
    3. Brooks DJ,
    4. et al

    . Extramotor involvement in ALS: PET studies with the GABA(A) ligand [(11)C]flumazenil. Brain 2000; 123 (Pt 11): 2289–96

    Abstract/FREE Full Text
15. 15.↵
    1. Rooney WD,
    2. Miller RG,
    3. Gelinas D,
    4. et al

    . Decreased N-acetylaspartate in motor cortex and corticospinal tract in ALS. Neurology 1998; 50: 1800–05

    Abstract/FREE Full Text
16. 16.↵
    1. Abe K,
    2. Takanashi M,
    3. Watanabe Y,
    4. et al

    . Decrease in N-acetylaspartate/creatine ratio in the motor area and the frontal lobe in amyotrophic lateral sclerosis. Neuroradiology 2001; 43: 537–41

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Block W,
    2. Karitzky J,
    3. Traber F,
    4. et al

    . Proton magnetic resonance spectroscopy of the primary motor cortex in patients with motor neuron disease: subgroup analysis and follow-up measurements. Arch Neurol 1998; 55: 931–36

    CrossRefPubMedWeb of Science
18. 18.↵
    1. Bowen BC,
    2. Pattany PM,
    3. Bradley WG,
    4. et al

    . MR imaging and localized proton spectroscopy of the precentral gyrus in amyotrophic lateral sclerosis. AJNR Am J Neuroradiol 2000; 21: 647–58

    Abstract/FREE Full Text
19. 19.↵
    1. Kalra S,
    2. Hanstock CC,
    3. Martin WR,
    4. et al

    . Detection of cerebral degeneration in amyotrophic lateral sclerosis using high-field magnetic resonance spectroscopy. Arch Neurol 2006; 63: 1144–48

    CrossRefPubMed
20. 20.↵
    1. Brooks BR,
    2. Miller RG,
    3. Swash M,
    4. et al

    . El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000; 1: 293–99

    CrossRefPubMedWeb of Science
21. 21.↵
    1. Strong MJ,
    2. Grace GM,
    3. Freedman M,
    4. et al

    . Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2009; 10: 131–46

    CrossRefPubMedWeb of Science
22. 22.↵
    1. Mathuranath PS,
    2. Nestor PJ,
    3. Berrios GE,
    4. et al

    . A brief cognitive test battery to differentiate Alzheimer's disease and frontotemporal dementia. Neurology 2000; 55: 1613–20

    Abstract/FREE Full Text
23. 23.↵
    1. Choi C,
    2. Ogilvie CJ,
    3. Malykhin N,
    4. et al

    . Detection of the myo-inositol 4.06-ppm resonance by selective J rewinding: application to human prefrontal cortex in vivo. Magn Reson Med 2005; 54: 1536–40

    CrossRefPubMed
24. 24.↵
    1. Govindaraju V,
    2. Young K,
    3. Maudsley AA

    . Proton NMR chemical shifts and coupling constants for brain metabolites. NMR Biomed 2000; 13: 129–53

    CrossRefPubMedWeb of Science
25. 25.↵
    1. Provencher SW

    . Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993; 30: 672–79

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Thompson RB,
    2. Allen PS

    . Sources of variability in the response of coupled spins to the PRESS sequence and their potential impact on metabolite quantification. Magn Reson Med 1999; 41: 1162–69

    CrossRefPubMed
27. 27.↵
    1. Choi C,
    2. Bhardwaj PP,
    3. Seres P,
    4. et al

    . Measurement of glycine in human brain by triple refocusing 1H-MRS in vivo at 3.0T. Magn Reson Med 2008; 59: 59–64

    CrossRefPubMed
28. 28.↵
    1. Choi C,
    2. Coupland NJ,
    3. Bhardwaj PP,
    4. et al

    . T2 measurement and quantification of glutamate in human brain in vivo. Magn Reson Med. 2006; 56: 971–77

    CrossRefPubMed
29. 29.↵
    1. Wansapura JP,
    2. Holland SK,
    3. Dunn RS,
    4. et al

    . NMR relaxation times in the human brain at 3.0 Tesla. J Magn Reson Imaging 1999; 9: 531–38

    CrossRefPubMedWeb of Science
30. 30.↵
    1. Traber F,
    2. Block W,
    3. Lamerichs R,
    4. et al

    . 1H metabolite relaxation times at 3.0 Tesla: Measurements of T1 and T2 values in normal brain and determination of regional differences in transverse relaxation. J Magn Reson Imaging 2004; 19: 537–45

    CrossRefPubMedWeb of Science
31. 31.↵
    1. Nagy D,
    2. Kato T,
    3. Kushner PD

    . Reactive astrocytes are widespread in the cortical gray matter of amyotrophic lateral sclerosis. J Neurosci Res 1994; 38: 336–47

    CrossRefPubMedWeb of Science
32. 32.↵
    1. Abrahams S,
    2. Leigh PN,
    3. Harvey A,
    4. et al

    . Verbal fluency and executive dysfunction in amyotrophic lateral sclerosis (ALS). Neuropsychologia 2000; 38: 734–47

    CrossRefPubMedWeb of Science
33. 33.↵
    1. Abrahams S,
    2. Goldstein LH,
    3. Simmons A,
    4. et al

    . Word retrieval in amyotrophic lateral sclerosis: a functional magnetic resonance imaging study. Brain 2004; 127: 1507–17

    Abstract/FREE Full Text
34. 34.↵
    1. Abrahams S,
    2. Goldstein LH,
    3. Suckling J,
    4. et al

    . Frontotemporal white matter changes in amyotrophic lateral sclerosis. J Neurol 2005; 252: 321–31

    CrossRefPubMedWeb of Science
35. 35.↵
    1. Hornak J,
    2. O'Doherty J,
    3. Bramham J,
    4. et al

    . Reward-related reversal learning after surgical excisions in orbito-frontal or dorsolateral prefrontal cortex in humans. J Cogn Neurosci 2004; 16: 463–78

    CrossRefPubMedWeb of Science
36. 36.↵
    1. Grossman AB,
    2. Woolley-Levine S,
    3. Bradley WG,
    4. et al

    . Detecting neurobehavioral changes in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2007; 8: 56–61

    CrossRefPubMedWeb of Science